Press release
Wound Care Biologics Market Trends, Overview And Forecast 2024-2033
Wound Care Biologics Market Trends
According to The Business Research Company's, The wound care biologics market size has grown strongly in recent years. It will grow from $1.76 billion in 2023 to $1.93 billion in 2024 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to clinical evidence and studies, regulatory framework development, wound care market evolution, limited treatment options, research and development efforts.
The wound care biologics market size is expected to see strong growth in the next few years. It will grow to $2.71 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to focus on personalized medicine, rise in healthcare expenditure, value-based healthcare models, growing demand for advanced therapies, regulatory support and approvals. Major trends in the forecast period include regenerative medicine emphasis, bioengineered skin substitutes, innovative delivery systems, rise in chronic wound management, patient-centric care.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/wound-care-biologics-global-market-report
Market Drivers and Trends:
The high prevalence of diabetes is expected to propel the growth of the wound care biologics market in the coming future. diabetes is a chronic metabolic condition characterized by high levels of blood glucose (or blood sugar), which causes catastrophic damage to the heart, blood vessels, eyes, kidneys, and nerves over time. Biological wound care prevents volatile water loss, heat loss, protein and electrolyte loss, and contamination. They also allow autolytic debridement and produce a granular wound layer. The high prevalence of diabetes is one of the factors driving the growth of the wound care biologics market. For instance, in December 2021, according to the IDF Diabetes Atlas Tenth Edition 2021 report published by the International Diabetes Federation, a Belgium-based umbrella organization of national diabetes associations, 537 million persons (20-79 years old) were estimated to have diabetes in 2021. By 2030, there will be 643 million diabetics worldwide, and by 2045, there will be 783 million. Therefore, the high prevalence of diabetes is driving the wound care biologics market.
Product innovation is a key trend gaining popularity in the consumer and wound care biologics market. Major companies operating in the wound care biologics market are focused on developing innovative products with advanced technologies to strengthen their position in the market. For instance, in April 2021, Kerecis, a US-based company used to treat wounds, burns, and other complex acute and chronic wounds, launched its Kerecis Omega3 GraftGuide. This fish skin is whole and specifically addresses the difficulties of burn healing. The product improves autograft take, lessens the need for autograft harvesting, and even serves as an alternative to autografting. The FDA approves it under the 510(k) regulatory procedure.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=10584&type=smp
Major Key Players of the Market:
Integra Lifesciences Corporation; Organogenesis Inc.; Smith and Nephew plc; Wright Medical Group NV; MiMedx Group Inc.; Kerecis AG; Amnio Technology LLC; Anika Therapeutics Inc.; ACell Inc.; Derma Sciences Inc.; Soluble Systems Pvt. Ltd.; Medline Industries LP; Solsys Medical LLC; Zimmer Biomet Holdings Inc.; MLM Biologics Inc.; Tissue Genesis LLC; Stryker Corporation; Marine Polymer Technologies Inc.; Bioventus Inc.; Mölnlycke Health Care AB; Lynch Biologics LLC; Skye Biologics Holdings LLC; Osiris Therapeutics Inc.; Vericel Corporation; TissueTech Inc.; PolarityTE Inc.; Avita Medical Limited; Celularity Inc.; Human Regenerative Technologies LLC; PolyRemedy Inc.
Wound Care Biologics Market 2024 Key Insights:
• The wound care biologics market will grow to $2.71 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%.
• Rising Prevalence Of Diabetes To Drive Market Growth
• Product Innovations Transforming The Wound Care Biologics Market
• North America was the largest region in the wound care biologics market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=10584&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Wound Care Biologics Market Trends, Overview And Forecast 2024-2033 here
News-ID: 3758300 • Views: …
More Releases from The Business research company
Global Fruit and Vegetable Seeds Market: Growth Drivers, Key Players, and Foreca …
Soaring to New Heights: The Fruit and Vegetable Seeds Market Set for Robust Growth with CAGR of 5.8%
What Is The Projected Market Size Of The Global Fruit and Vegetable Seeds Market And Its Growth Rate?
The Fruit and Vegetable Seeds market has displayed impressive growth. Below are the key statistics:
• The market size grew from $10.66 billion in 2024 to $11.21 billion in 2025, demonstrating a compound annual growth rate (CAGR)…
Fire Stopping Material Market: Growth Drivers, Key Players, and Trends Through 2 …
Fire Stopping Material Market: Boosting CAGR, Dominant Prevalence and Stake in the Construction Industry
What Is The Projected Market Size Of The Global Fire Stopping Material Market And Its Growth Rate?
The impressive growth of the fire stopping material market is primarily informed by the listed facts and figures:
• The market worth rose from $1.64 billion in 2024 to $1.8 billion in 2025, reflecting a CAGR of 9.6%
• The growth has been…
Soaring Generic Injectables Market Predicted: Key Insights and Forecasts up to 2 …
The generic injectables market continues to surge, traversing current trends and market drivers
What Is The Projected Market Size Of The Global Generic Injectables Market And Its Growth Rate?
• The generic injectables market size has grown rapidly in recent years, growing from $124.61 billion in 2024 to $143.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%.
• The growth of the market in the historic period is attributable…
Burgeoning Fashion Design And Production Software Market: Projected to Reach $4. …
Improved Digital Supply Chains and E-commerce Expansion drive the fashion design and production software market.
What Is The Projected Market Size Of The Global Fashion Design And Production Software Market And Its Growth Rate?
The fashion design and production software market is experiencing significant growth. The key growth projections include:
• 2024 Market Size: $2.46 billion
• 2025 Market Size: $2.67 billion (8.5% CAGR)
• 2029 Market Size: $4.04 billion (10.9% CAGR)
Market growth in the…
More Releases for Biologics
Biopharmaceutical CMO Market 2020 Business Scenario – Lonza, Boehringer Ingelh …
The report provides a valuable source of insightful data for business strategists and competitive analysis of Biopharmaceutical CMO Market. It provides the Biopharmaceutical CMO industry overview with growth analysis and futuristic cost, revenue and many other aspects. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Biopharmaceutical CMO study provides comprehensive data which enhances the understanding, scope and application of this report.
the…
Extracellular Matrix Market Detailed Analysis 2020: Top Companies like Coloplast …
The global extracellular matrix market by raw material segments was led by porcine segment. In 2018, the porcine segment held a largest market share of 41.09% of the extracellular matrix market, by raw material. However, the bovine segment is expected to be the fastest growing segments of the market in 2027 owing to more beneficial properties to treat various conditions which is expected to become the major factor for the…
Biopharmaceutical CMO Market 2018-2023 :Lonza, Boehringer Ingelheium, Samsung Bi …
Global Biopharmaceutical CMO Industry - A Global Market Overview (2018-2023) (Avail A 10% Off)
The "Global Biopharmaceutical CMO Market Research Report 2018-2023" is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides…
Global Biopharmaceutical CMO Market Key Profiles - Wuxi Biologics, Boehringer In …
Global Biopharmaceutical CMO Market was valued at USD 13296.29 million in the year 2019. Escalating number of patients suffering from various diseases with growing investment in the healthcare industry by government in major economies and increasing awareness among consumers regarding impact of various viruses on health, has been anticipated to infuse growth in the market for Biopharmaceutical CMO during the forecasting period of 2020-2025.
Get Free Sample Copy of this Research…
Plant-based Biologics
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development…
Global Biopharmaceutical CMO Market 2018-2023| Lonza, Boehringer Ingelheium, Sam …
Albany, NY, 10th September : Recent research and the current scenario as well as future market potential of "Global Biopharmaceutical CMO Market - Analysis By Region, By Country: Opportunities and Forecast (2018-2023) - By Region (North America, Europe, APAC), By Country (U.S, Denmark, Germany, Switzerland, Korea, Japan, China)" globally.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to…
